Bespoke Extracts (BSPK) Cost of Revenue (2018 - 2025)
Bespoke Extracts (BSPK) reported Cost of Revenue of $233770.0 for Q3 2025, up 43.88% on a YoY basis from $162476.0 in Q3 2024, and up 21.09% sequentially from $193054.0 in Q2 2025.
Bespoke Extracts (BSPK) Cost of Revenue (2018 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 8 years of Cost of Revenue data on file, last reported at $233770.0 in Q3 2025.
- For the quarter ending Q3 2025, Cost of Revenue rose 43.88% year-over-year to $233770.0; the trailing twelve-month figure through Sep 2025 stood at $751352.0 (up 26.75% YoY), and the FY2024 full-year result was $664517.0, up 50.24% from the prior year.
- Cost of Revenue climbed to $233770.0 in Q3 2025, from $193054.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $233770.0 in Q3 2025 to a low of -$46431.0 in Q4 2022.
- A 5-year average of $89824.2 and a median of $100411.0 in 2023 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue decreased 8.94% in 2021 and soared 224515.38% in 2023, its largest moves.
- Tracing BSPK's Cost of Revenue over 5 years: stood at $1864.0 in 2021, then plunged by 2590.93% to -$46431.0 in 2022, then soared by 316.26% to $100411.0 in 2023, then jumped by 71.44% to $172148.0 in 2024, then surged by 35.8% to $233770.0 in 2025.
- Business Quant data shows BSPK's Cost of Revenue at $233770.0 in Q3 2025, $193054.0 in Q2 2025, and $152380.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 233,770.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 233,770.00 |
| Sep 30, 2025 | 233,770.00 |
| Jun 30, 2025 | 193,054.00 |
| Jun 30, 2025 | 193,054.00 |
| Mar 31, 2025 | 152,380.00 |
| Mar 31, 2025 | 152,380.00 |
| Dec 31, 2024 | 172,148.00 |
| Dec 31, 2024 | 172,148.00 |
| Sep 30, 2024 | 162,476.00 |
| Sep 30, 2024 | 162,476.00 |
| Jun 30, 2024 | 172,046.00 |
| Jun 30, 2024 | 172,046.00 |
| Mar 31, 2024 | 157,847.00 |
| Mar 31, 2024 | 157,847.00 |
| Dec 31, 2023 | 100,411.00 |
| Dec 31, 2023 | 100,411.00 |
| Sep 30, 2023 | 146,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 117,211.00 |
| Jun 30, 2023 | 117,211.00 |